Integer Holdings Corporation (NYSE:ITGR) Stock Now Rated “Hold” by Wall Street Analysts

Integer Holdings Corporation (NYSE:ITGR) has been given a consensus recommendation of “Hold” by the fourteen analysts that are covering the stock, MarketBeat Ratings reports. Thirteen analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $109.86.

ITGR has been the topic of a number of analyst reports. HC Wainwright reiterated a “buy” rating on shares of Integer in a research note on Friday, July 24th. Piper Sandler downgraded Integer from an “overweight” rating to a “hold” rating and set a $127.00 target price for the company. in a research note on Monday, August 3rd. KeyCorp downgraded Integer from an “overweight” rating to a “sector weight” rating in a research note on Monday, August 3rd. Oppenheimer lowered Integer from an “outperform” rating to a “market perform” rating in a report on Monday, August 3rd. Finally, Wells Fargo & Company upped their price target on Integer from $84.00 to $127.00 and gave the company an “equal weight” rating in a research report on Tuesday, August 4th.

Integer Stock Down 0.0%

ITGR opened at $126.60 on Thursday. The company has a 50 day moving average of $125.84 and a 200 day moving average of $103.43. The company has a market cap of $4.30 billion, a PE ratio of 34.59, a price-to-earnings-growth ratio of 2.41 and a beta of 0.58. Integer has a 12 month low of $62.00 and a 12 month high of $126.79. The company has a current ratio of 3.73, a quick ratio of 2.41 and a debt-to-equity ratio of 0.75.

Integer (NYSE:ITGR) last issued its earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.38 by $0.22. The business had revenue of $464.11 million for the quarter, compared to analysts’ expectations of $451.07 million. Integer had a net margin of 6.97% and a return on equity of 12.79%. The business’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.55 EPS. On average, sell-side analysts expect that Integer will post 6.09 EPS for the current year.

Insider Buying and Selling

In other news, insider Andrew Senn sold 9,408 shares of the firm’s stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $126.30, for a total value of $1,188,230.40. Following the completion of the transaction, the insider directly owned 5,405 shares in the company, valued at approximately $682,651.50. This trade represents a 63.51% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Kirk Thor sold 19,773 shares of the business’s stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $126.25, for a total transaction of $2,496,341.25. Following the transaction, the insider directly owned 18,920 shares of the company’s stock, valued at approximately $2,388,650. This represents a 51.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 40,948 shares of company stock valued at $5,169,920 over the last 90 days. 1.10% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. GAMMA Investing LLC lifted its stake in Integer by 12.7% during the third quarter. GAMMA Investing LLC now owns 4,335 shares of the medical equipment provider’s stock worth $548,000 after purchasing an additional 489 shares during the last quarter. Farther Finance Advisors LLC boosted its holdings in shares of Integer by 64.4% in the 3rd quarter. Farther Finance Advisors LLC now owns 490 shares of the medical equipment provider’s stock worth $62,000 after purchasing an additional 192 shares in the last quarter. Canandaigua National Bank & Trust Co. purchased a new position in shares of Integer in the 3rd quarter worth about $253,000. HBK Investments L P purchased a new position in shares of Integer in the 2nd quarter worth about $14,502,000. Finally, Sequoia Financial Advisors LLC increased its position in shares of Integer by 4.7% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 3,180 shares of the medical equipment provider’s stock valued at $297,000 after purchasing an additional 142 shares during the last quarter. 99.29% of the stock is owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a medical device contract development and manufacturing company. The company designs, develops and manufactures components and finished products for medical device manufacturers, helping customers bring products from concept and development through commercial production.

Integer’s products and technologies support a range of medical applications, including cardiac and vascular devices, neuromodulation systems, orthopedics, and other specialty medical products.